Care of the critically ill patient with advanced chronic kidney disease or end-stage renal disease

Current Opinion in Critical Care

Volumn 18, Issue 6, 2012, Pages 599-606

  Hotchkiss, John R ^a,b   Palevsky, Paul M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

chronic kidney disease; critical care; end stage renal disease; prognosis

Indexed keywords

ANTIBIOTIC AGENT; GADOLINIUM; IODINATED CONTRAST MEDIUM;

ANTIBIOTIC RESISTANCE; BACTEREMIA; CATHETER INFECTION; CHRONIC KIDNEY DISEASE; CONTRAST ENHANCEMENT; CRITICALLY ILL PATIENT; DISEASE SEVERITY; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SCORING SYSTEM; VASCULAR ACCESS;

COMORBIDITY; CRITICAL CARE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84870249961     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32835a1c59     Document Type: Review

References (36)

1. United States Renal Data System Annual data report. National Institutes of Health; National Institutes of Diabetes and Digestive and Kidney Diseases. Bethesda, Maryland; 2011.
2. Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377; PMID: 11794169.
3. Wiedemann HP, Wheeler AP, Bernard GR, et al. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575. (Pubitemid 43882352)
4. Humphrey H, Hall J, Sznajder I, et al. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97:1176-1180. (Pubitemid 20166812)
5. Castillo R, Lozano T, Escolar G, et al. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 1986; 68:337-342. (Pubitemid 16050650)
6. Fernandez F, Goudable C, Sie P, et al. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 1985; 59:139-148. (Pubitemid 15188829)
7. Escolar G, Cases A, Bastida E, et al. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 1990; 76:1336-1340. (Pubitemid 20342748)
8. Lee HK, Kim YJ, Jeong JU, et al. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clin Pract 2010; 114:c248-c252.
9. Noris M, Todeschini M, Zappella S, et al. 17beta-estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases. Am J Physiol Renal Physiol 2000; 279:F626-F635.
10. Viganò G, Gaspari F, Locatelli M, et al. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 1988; 34:853-858. (Pubitemid 19001705)
11. Girndt M, Sester U, Sester M, et al. Impaired cellular immune function inpatients with end-stage renal failure. Nephrol Dial Transplant 1999; 14:2807-2810.
12. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001; 15:813-832. (Pubitemid 32852820)
13. Pop-Vicas A, Strom J, Stanley K, D'Agata EM. Multidrug-resistant Gramnegative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 2008; 3:752-758.
14. D'Agata EM. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 2002; 35:1212-1218. (Pubitemid 35305869)
15. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999; 340:493-501.
16. Chang S, Sievert DM, Hageman JC, et al. Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1342-1347. (Pubitemid 36384101)
17. Hutchison CA, Crowe AV, Stevens PE, et al. Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2007; 11:R50.
18. Strijack B, Mojica J, Sood M, et al. Outcomes of chronic dialysis patients admitted to the intensive care unit. J Am Soc Nephrol 2009; 20:2441-2447.
19. Ostermann M, Chang R. Riyadh ICU Program Users Group. Renal failure in the intensive care unit: acute kidney injury compared to end-stage renal failure. Crit Care 2008; 12:432.
20. Clermont G, Acker CG, Angus DC, et al. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002; 62:986-996. (Pubitemid 35316729)
21. Dara SI, Afessa B, Bajwa AA, Albright RC. Outcome of patients with endstage renal disease admitted to the intensive care unit. Mayo Clin Proc 2004; 79:1385-1390. (Pubitemid 39453302)
22. Senthuran S, Bandeshe H, Ranganathan D, Boots R. Outcomes for dialysis patients with end-stage renal failure admitted to an intensive care unit or high dependency unit. Med J Aust 2008; 188:292-295.
23. Bell M, Granath F, Schön S, et al. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome. Crit Care Med 2008; 36:2773-2778.
24. Manhes G, Heng AE, Aublet-Cuvelier B, et al. Clinical features and outcome of chronic dialysis patients admitted to an intensive care unit. Nephrol Dial Transplant 2005; 20:1127-1133. (Pubitemid 40862101)
25. Uchino S, Morimatsu H, Bellomo R, et al. End-stage renal failure patients requiring renal replacement therapy in the intensive care unit: incidence, clinical features, and outcome. Blood Purif 2003; 21:170-175. (Pubitemid 36302368)
26. Juneja D, Prabhu MV, Gopal PB, et al. Outcome of patients with end stage renal disease admitted to an intensive care unit in India. Ren Fail 2010; 32:69-73.
27. Rocha E, Soares M, Valente C, et al. Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study. Nephrol Dial Transplant 2009; 24:1925-1930.
28. Sood MM, Roberts D, Komenda P, et al. End-stage renal disease status and critical illness in the elderly. Clin J Am Soc Nephrol 2011; 6:613-619.
29. Chapman RJ, Templeton M, Ashworth S, et al. Long-term survival of chronic dialysis patients following survival from an episode of multiple-organ failure. Crit Care 2009; 13:R65.
30. Sood MM, Miller L, Komenda P, et al. Long-term outcomes of end-stage renal disease patients admitted to the ICU. Nephrol Dial Transplant 2011; 26:2965-2970.
31. Bagshaw SM, Mortis G, Doig CJ, et al. One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment. Am J Kidney Dis 2006; 48:402-409. (Pubitemid 44262426)
32. Fistula First Website: http://fistulafirst.org/LinkClick.aspx?fileticket= B5wQhmkbwvo%3d&tabid=205. [Accessed 10 August 2012].
33. Choosing Wisely: http://choosingwisely.org/wp-content/uploads/2012/04/ 5things-12-factsheet-Amer-Soc-Neph.pdf. [Accessed 10 August 2012].
34. Reiter T, Ritter O, Prince MR, et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14:31.
35. Cruz DN, Goh CY, Marenzi G, et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Med 2012; 125:66-78; e3.
36. Weisbord SD, Palevsky PM. Iodinated contrast media and the role of renal replacement therapy. Adv Chronic Kidney Dis 2011; 18:199-206.